Biological Assembly 1  

 3D View: Structure | Electron Density | Ligand Interaction

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 

Biological assembly 1 assigned by authors and generated by PQS (software)

Macromolecule Content

• Total Structure Weight: 37.81 kDa 
• Atom Count: 2530 
• Modelled Residue Count: 307 
• Deposited Residue Count: 327 
• Unique protein chains: 1

2ITX

Crystal structure of EGFR kinase domain in complex with AMP-PNP

• DOI: 10.2210/pdb2ITX/pdb

• Classification: TRANSFERASE
• Organism(s): Homo sapiens
• Expression System: Spodoptera frugiperda
• Mutation(s): No 


• Deposited: 2006-05-25 Released: 2007-04-03 
• Deposition Author(s): Yun, C.-H., Boggon, T.J., Li, Y., Woo, S., Greulich, H., Meyerson, M., Eck, M.J.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.98 Å
• R-Value Free: 0.261 
• R-Value Work: 0.188 
• R-Value Observed: 0.191 

Literature

Structures of Lung Cancer-Derived Egfr Mutants and Inhibitor Complexes: Mechanism of Activation and Insights Into Differential Inhibitor Sensitivity

Yun, C.-H., Boggon, T.J., Li, Y., Woo, S., Greulich, H., Meyerson, M., Eck, M.J.

(2007) Cancer Cell 11: 217

• PubMed: 17349580 
• DOI: 10.1016/j.ccr.2006.12.017
• Primary Citation of Related Structures:  
  2ITT, 2ITQ, 2ITP, 2ITO, 2ITN, 2ITZ, 2ITY, 2ITX, 2ITW, 2ITV


• PubMed Abstract: 
  

Mutations in the EGFR kinase are a cause of non-small-cell lung cancer. To understand their mechanism of activation and effects on drug binding, we studied the kinetics of the L858R and G719S mutants and determined their crystal structures with inhibitors including gefitinib, AEE788, and a staurosporine. We find that the mutations activate the kinase by disrupting autoinhibitory interactions, and that they accelerate catalysis as much as 50-fold in vitro. Structures of inhibitors in complex with both wild-type and mutant kinases reveal similar binding modes for gefitinib and AEE788, but a marked rotation of the staurosporine in the G719S mutant. Strikingly, direct binding measurements show that gefitinib binds 20-fold more tightly to the L858R mutant than to the wild-type enzyme.

---

Organizational Affiliation: 

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, MA 02115, USA.

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
EPIDERMAL GROWTH FACTOR RECEPTOR	A	327	Homo sapiens	Mutation(s): 0  Gene Names: EGFR, ERBB, ERBB1, HER1 EC: 2.7.10.1
Find proteins for P00533 (Homo sapiens) Explore P00533  Go to UniProtKB:  P00533
NIH Common Fund Data Resources
PHAROS:  P00533 GTEx:  ENSG00000146648

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
ANP	B [auth A]	PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER C10 H17 N6 O12 P3 PVKSNHVPLWYQGJ-KQYNXXCUSA-N

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.98 Å
• R-Value Free: 0.261 
• R-Value Work: 0.188 
• R-Value Observed: 0.191 
• Space Group: I 2 3

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 144.461	α = 90
b = 144.461	β = 90
c = 144.461	γ = 90

Software Package:

Software Name	Purpose
REFMAC	refinement
HKL-2000	data reduction
HKL-2000	data scaling
PHASER	phasing

Structure Validation

Entry History 

Deposition Data

• Deposited Date: 2006-05-25 
• Released Date: 2007-04-03 
Deposition Author(s): Yun, C.-H., Boggon, T.J., Li, Y., Woo, S., Greulich, H., Meyerson, M., Eck, M.J.

Revision History  

• Version 1.0: 2007-04-03
  Type: Initial release
  
• Version 1.1: 2011-06-02
  Changes: Version format compliance
• Version 1.2: 2011-07-13
  Changes: Version format compliance